Associate Professor Andrew Wirth graduated medicine at the University of Melbourne in 1981 and after completing training in medical and radiation oncology, was appointed consultant radiation oncologist at the Peter MacCallum Cancer Centre. He completed his MD Thesis on “The role of radiotherapy and imaging in the management of haematological malignancies” through the University of Melbourne in 2009. His areas of clinical expertise include the management of haematological, thoracic and CNS malignancies. His research has focused on radiotherapy for initial and salvage therapy for a range of lymphomas and the use of PET scanning for staging and response assessment in lymphomas. He has been lead investigator on national clinical trials through the Australasian Leukaemia Lymphoma Group and the Trans-Tasman Radiation Oncology Group, as well as lead investigator on an International Extra-nodal Lymphoma Study Group study. He is on the editorial board of Leukemia and Lymphoma, a has been a member of the UICC TNM Expert Advisory Panel on Lymphoma and on the scientific advisory committee for aggressive lymphomas of the Australasian Leukaemia and Lymphoma Group. He has served on State and National guidelines committees for lymphoma. He is a founding member of the International Lymphoma Radiation Oncology Group and has been involved in several key guideline publications on involved-site radiotherapy. He led the radiation oncology section of the haematology service at the Peter MacCallum Cancer Centre and the Box Hill Campus for over 20 years.